激素疗法可降低绝经期妇女精神病复发的风险

The Brown University Psychopharmacology Update Pub Date : 2024-11-26 DOI:10.1002/pu.31252

{"title":"激素疗法可降低绝经期妇女精神病复发的风险","authors":"","doi":"10.1002/pu.31252","DOIUrl":null,"url":null,"abstract":"<p>Women of menopausal age with schizophrenia or schizoaffective disorder who used menopausal hormone therapy experienced a reduced risk of psychotic relapse compared with non-use, a study using a within-individual design has found. Relapse risk was decreased in women who initiated hormone therapy between the ages of 40 and 55.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 1","pages":"3"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hormone therapy reduces psychotic relapse risk in women of menopausal age\",\"authors\":\"\",\"doi\":\"10.1002/pu.31252\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Women of menopausal age with schizophrenia or schizoaffective disorder who used menopausal hormone therapy experienced a reduced risk of psychotic relapse compared with non-use, a study using a within-individual design has found. Relapse risk was decreased in women who initiated hormone therapy between the ages of 40 and 55.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"36 1\",\"pages\":\"3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31252\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31252","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

一项采用个体内设计的研究发现，使用更年期荷尔蒙疗法的更年期精神分裂症或分裂情感障碍女性比不使用更年期荷尔蒙疗法的女性精神病复发风险更低。年龄在40至55岁之间开始接受激素治疗的女性复发风险较低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Hormone therapy reduces psychotic relapse risk in women of menopausal age

Women of menopausal age with schizophrenia or schizoaffective disorder who used menopausal hormone therapy experienced a reduced risk of psychotic relapse compared with non-use, a study using a within-individual design has found. Relapse risk was decreased in women who initiated hormone therapy between the ages of 40 and 55.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Brown University Psychopharmacology Update

自引率

0.00%

发文量